Robert G Micheletti, MD

faculty photo
Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
Department: Dermatology

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
7th Floor, South Tower, Room 724
Philadelphia, PA 19104-4283
Office: 215-662-2737
Stanford University , 2004.
Duke University School of Medicine, 2008.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Micheletti RG: Graft-versus-Host Disease. Treatment of Skin Disease, 6th ed Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I (eds.). Elsevier, Oct 2021.

Micheletti RG: Featured in "Systematic approach to pain helps avoid opioid issues for dermatologists" MD-Edge Dermatology May 2021.

Micheletti RG: Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Podcast for JAMA Dermatology May 2021.

Hoffman M, Chansky PB, Bashyam AR, Boettler MA, Challa N, Dominguez A, Estupinan B, Gupta R, Hennessy K, Huckell SN, Hylwa-Deufel S, Karikari NA, Keller JJ, Kroshinsky D, Kullberg SA, Lake E, Lee KJ, Martinez E, Michels K, Mostaghimi A, Murphy W, Nutan F, Osler M, Pahalyants V, Patel T, Seminario-Vidal L, Strowd LC, Trinidad J, Vaudreuil A, Voller LM, Micheletti RG: Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. JAMA Dermatol May 2021 Notes: Online ahead of print.

Hoffman M, Smith RJ, Micheletti RG, Rosenbach M: Dermatologic Support for Oncology: Quantifying the consultative services received by hospitalized oncology patients. J Am Acad Dermatol May 2021 Notes: Online ahead of print.

Ghias MH, Johnston AD, Kutner AJ, Micheletti RG, Hosgood HD, Cohen SR: Authors' Reply to the comment 'High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa'. J Am Acad Dermatol 84(4): e203-e204, Apr 2021.

Walls AC, Din RS, Okhovat JP, Chansky PB, Micheletti RG*, Mostaghimi A* (*denotes equal contribution).: Low Utility of Radiological Imaging in Evaluating Cutaneous Small-Vessel Vasculitis: A Multi-institutional Retrospective Study J Am Acad Dermatol 84(4): 1197-1199. Apr 2021.

Abdalla T, Lowes MA, Kaur N, Micheletti RG, Steinhart AH, Alavi A.: Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors? Am J Clin Dermatol 22(2): 139-147, Mar 2021.

Caplan A, Micheletti RG: Advances in cutaneous vasculitis research and clinical care. Ann Transl Med 9((5)): 439, Mar 2021.

Brüggen MC, Le ST, Walsh S, Toussi A, de Prost N, Ranki A, Didona B, Colin A, Horváth B, Brezinova E, Milpied B, Moss C, Bodemer C, Meyersburg D, Salavastru C, Tiplica GS, Howard E, Bequignon E, Bouwes Bavinck JN, Newman J, Gueudry J, Nägeli M, Zaghbib K, Pallesen K, Bygum A, Joly P, Wolkenstein P, Chua SL, Le Floch R, Shear NH, Chu CY, Hama N, Abe R, Chung WH, Shiohara T, Arden-Jones M, Romanelli P, Phillips EJ, Stern RS, Cotliar J, Micheletti RG, Brassard A, Schulz JT, Dodiuk-Gad RP, Dominguez AR, Paller AS, Vidal LS, Mostaghimi A, Noe MH, Worswick S, Tartar D, Sheridan R, Kaffenberger BH, Shinkai K, Maverakis E, French LE, Ingen-Housz-Oro S: Supportive care in the acute phase of Stevens-Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus. Br J Dermatol Mar 2021 Notes: Online ahead of print.

back to top
Last updated: 05/12/2021
The Trustees of the University of Pennsylvania